Smartphone ECG Monitor Detects Atrial Fibrillation (A-Fib)
May 19, 2014
Another study released at the Heart Rhythm Society’s Annual meeting reveals a new Wireless Cardiac Monitor used for monitoring patients for Atrial Fibrillation after an ablation procedure has been performed. The device is made by AliveCor a company that specializes in integrating wireless cardiac monitoring technology with today’s most common smart phones such as an iPhone and many others.
There were a total of 3 studies released that demonstrate the clinical utility of the AliveCor wireless ECG device. The details of the study include:
- iTransmit Study – focused on monitoring patients post ablation procedure. The study of 38 patients compared the Smart phone ECG device to standard transtelephonic cardiac event monitoring resulting in 100% sensitivity & 95% specificity in detection Atrial Fibrillation (A Fib) with the AliveCor device.
- SPEAR TRIA – this prospective trial evaluated the use of the AliveCor Heart Monitor in 30 patients with potential and diagnosed arrhythmias. Preliminary data demonstrated that the AliveCor Heart Monitor can generate accurate tracings in the remote setting in the pediatric population. In addition, patient and parent experience with the device was overwhelmingly positive; 95% of survey responses indicated the device was easy to use and 95% prefer to continue using the device once the study ends.
- “Wireless Smart Phone Equipped ECG Enables Large Scale Screening in Diverse Populations,” – evaluated the accuracy of the AliveCor wireless monitor compared to a 12-lead ECG with 382 patients. The Smart phone ECG device demonstrated a sensitivity and specificity for the detection of AF/atrial flutter of 94.4% and 99.3%, respectively.
